Healthtech Startups

Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.

1 investor

Myontec develops wearable technology (MShorts Plus and MSleeves) that monitors muscle activation and load in real time across quadriceps, hamstrings, glutes, and adductors for team sports athletes and coaches focused on performance optimization and injury prevention.

1 investor

Myoptechs develops treatments and interventions for myopia, a progressive eye disease that causes worsening distance vision and can lead to sight-threatening complications. The company targets patients and their eye care providers seeking to reduce both short- and long-term vision complications from myopia.

1 investor

Myospan develops smarter protein systems and science-based guidance focused on muscle longevity and healthy aging, targeting adults 35+ who want to maintain strength, recovery, and mobility. It offers a coaching program (the Muscle Longevity System), a podcast, and educational guides on nutrition, amino acids, and resistance training.

1 investor

MyPlesh creates reduced-sugar chocolate snacks that maintain traditional taste and texture without high sugar content. The company targets consumers seeking indulgent treats without guilt or health compromises.

1 investor

MySecondEar is Germany's leading digital hearing aid provider, offering hearing devices, accessories, and professional fitting services both online and at physical locations. The company serves customers seeking accessible, transparent hearing solutions through a combination of digital and in-person support.

1 investor

MySwimPro provides personalized swim training and coaching through mobile and wearable apps for swimmers worldwide. The platform combines fitness technology with swim coaching expertise to help users improve their swimming ability and achieve their fitness goals.

1 investor

MyTrials provides a platform helping patients and families navigate and find clinical trials through AI-driven technology. The service addresses the complexity of trial discovery for individuals seeking medical research participation opportunities.

1 investor

MyUTI is a platform providing UTI testing and support services for women with frequent and stubborn urinary tract infections. The company addresses gaps in women's health diagnostics and treatment by offering reliable testing solutions and clinical guidance.

1 investor

Covetrus operates an online veterinary pharmacy with home delivery and compounding services, plus a connected platform that integrates prescription workflows into veterinary practice operations. It serves veterinary practices, helping them manage prescriptions, improve treatment compliance, and generate revenue.

1 investor

My Well Self is an online wellness care navigation platform that bridges conventional and complementary medicine to improve health outcomes and reduce preventable chronic conditions for individuals, employers, and governments.

1 investor

NAAMA Studios provides laser tattoo removal and permanent makeup removal services using proprietary LightSense® technology, an FDA-cleared and clinically-backed system designed for safety and efficacy across all skin types.

1 investor

Based on the page listing "Ophthalmic Pharmaceutical Consultant" and "Chief Clinical Officer" roles, Nacuity appears to be a pharmaceutical company focused on ophthalmology (eye care), though the page provides insufficient detail to confirm products, customer base, or market focus.

1 investor

NADMED offers laboratory kits and analytical services for quantifying NAD and glutathione metabolites in research and diagnostic applications. The company provides CE-marked diagnostic kits, research-use-only kits, and custom quantification services for researchers and labs studying redox metabolism.

1 investor

Naegis Pharmaceuticals is a drug discovery and development company creating first-in-class small-molecule treatments for serious ophthalmic and inflammatory diseases. Its work targets inflammatory mechanisms, including leukotriene pathways, to develop new therapies for eye diseases.

1 investor

Rylo builds accessibility tools for Deaf and hard of hearing people, providing real-time communication solutions that preserve the richness of speech and integrate sign language research. The company serves the aging, deaf, and hard of hearing communities through dedicated support and community-centered product development.

1 investor

Nahtlos develops medical electrodes designed for reliable performance in long-term medical applications.

1 investor

Naitur provides AI automation solutions for independent health and wellness practices to improve client acquisition and operational efficiency. The company also collaborates with mental health research labs to build AI automation solutions that accelerate scientific discovery.

1 investor

Nakamo builds AI companions for medical device manufacturers to monitor technical documentation for consistency, completeness, and traceability within existing systems. The platform helps MedTech teams reduce time spent on documentation cross-checking and compliance work.

1 investor

Nami Surgical is a company developing surgical technology and seeks investors and partners across clinical, commercial, and technological domains. The company is based in Glasgow, United Kingdom.

1 investor

A firm that guides management and strategy for innovations in outpatient spine surgery.

1 investor

NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.

1 investor

NanoDx develops point-of-care diagnostic devices using nanowire biosensor technology to deliver rapid test results at patient locations, targeting unmet clinical needs globally.

1 investor

Nanodropper makes an FDA-listed, sterile twist-on adaptor that attaches to eyedrop bottles to dispense smaller drops, reducing medication waste and extending bottle life. It serves patients using glaucoma, dry eye, cataract, and myopia eyedrops, as well as optometry and ophthalmology clinics.

1 investor